Aberdare Ventures
Aberdare Ventures offers the healthcare industry with seed, early, and later stage venture, private equity, and grants investments.
Business Model:
Revenue: $17.6M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Aberdare Ventures Information
Geographic Data
Address: 235 Montgomery St
City: San Francisco
State: CA
Zip: 94104
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Aberdare Ventures is a venture firm that focuses on a limited number of entrepreneurial teams committed to building leading healthcare technology companies. They limit their commitments in the belief that their involvement can increase the probability of success for their portfolio companies and generate greater returns for their investors.
Contact Phone:
+14153927442
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 12/2006 | Posit Science | Series B | 14.5M |
| 6/2011 | Aviir | Venture Round | 3M |
| 4/2009 | Posit Science | Venture Round | 5.6M |
| 4/2013 | Cervel Neurotech | Venture Round | 14.1M |
| 9/1999 | CapitalThinking | Series A | 3.4M |
| 3/2014 | Gravie | Series A | 0 |
| 6/2008 | VertiFlex | Series C | 28.3M |
| 6/2002 | Salmedix | Series B | 27.5M |
| 3/2005 | Sequoia Pharmaceuticals | Series B | 22M |
| 11/2002 | Anacor Pharmaceutical | Venture Round | 4M |
| 12/2010 | Jiff | Seed Round | 1M |
| 8/2004 | Avera Pharmaceutical | Series C | 0 |
| 1/2007 | VertiFlex | Series B | 20M |
| 11/2000 | Microbia | Series B | 0 |
| 9/2013 | Adavium | Private Equity Round | 20M |
| 5/2005 | Anacor Pharmaceutical | Series C | 25M |
| 9/2014 | Jiff | Series B | 0 |
| 11/2012 | Wello | Seed Round | 1M |
| 3/2012 | Viracta Therapeutics | Series B | 0 |
| 6/2015 | Realeve | Series D | 43.2M |
| 2/2011 | VertiFlex | Venture Round | 14M |
| 7/2017 | Gravie | Series C | 0 |
| 4/2010 | Viracta Therapeutics | Series B | 12M |
| 8/2006 | Kemia | Series C | 0 |
| 10/2011 | Realeve | Series C | 32M |
| 5/2015 | Jiff | Series C | 0 |
| 6/2007 | Paracor Medical | Series D | 44M |
| 5/2006 | Eledon Pharmaceuticals | Series B | 35M |
| 3/2011 | Posit Science | Venture Round | 3.1M |
| 3/2014 | goBalto | Venture Round | 0 |
| 2/2011 | Conatus Pharmaceuticals | Series B | 0 |
| 4/2015 | Gravie | Series B | 0 |
| 3/2012 | Jiff | Series A | 7.5M |
| 12/2008 | Aviir | Venture Round | 7.8M |
| 9/2010 | EnteroMedics | Post-IPO Equity | 6.3M |
| 9/2012 | RxAnte | Series A | 4.6M |
| 1/2015 | goBalto | Series C | 0 |
| 10/2009 | Aviir | Venture Round | 1M |
| 9/2007 | Aviir | Series B | 11.3M |
| 6/2013 | Aviir | Series B | 10M |
| 1/2010 | Aviir | Venture Round | 4.2M |
| 5/2006 | KAI Pharmaceuticals | Series B | 35M |
| 12/2006 | NBI Development | Seed Round | 5.5M |
| 7/2005 | VertiFlex | Series A | 6.3M |
| 12/2011 | Aviir | Venture Round | 10M |
| 3/2008 | Aviir | Venture Round | 1.5M |
| 1/2009 | Anacor Pharmaceutical | Series E | 0 |
| 10/2011 | NxThera | Series B | 0 |
| 1/2007 | Sequoia Pharmaceuticals | Series C | 35M |
| 9/2013 | Advance Medical | Series B | 20M |
| 9/2018 | Cricket Health | Series A | 0 |
| 6/2004 | Idun Pharmaceuticals | Venture Round | 0 |
| 7/2002 | Anacor Pharmaceutical | Series A | 2.9M |
| 12/2001 | Pharmion | Venture Round | 65M |
| 4/2000 | Alibris | Series D | 30M |
| 7/2011 | Nevro | Series B | 58M |
| 2/2009 | Mpex Pharmaceuticals | Series D | 27.5M |
| 12/2006 | Nevro | Seed Round | 5.5M |
| 9/2008 | Nevro | Series A | 21.8M |
| 5/2009 | Clovis Oncology | Venture Round | 145M |
| 1/2011 | Rock Health | Grant | 0 |
| 8/2018 | MC10 | Venture Round | 0 |
| 12/2011 | Omada Health | Seed Round | 800k |
| 9/2008 | Cervel Neurotech | Series A | 1.5M |
| 5/2007 | Conatus Pharmaceuticals | Series A | 22M |
| 2/2013 | Aviir | Series B | 10M |
| 8/2005 | Mpex Pharmaceuticals | Series B | 0 |
| 5/2015 | Realeve | Series D | 38M |
| 1/2012 | MC10 | Venture Round | 2M |
| 10/2012 | Bluesight | Seed Round | 100k |
| 12/2012 | goBalto | Series B | 0 |
| 12/2012 | MC10 | Series C | 10M |
| 7/2007 | Ablation Frontiers | Series C | 0 |
| 9/2018 | Cricket Health | Series A | 0 |
| 8/2018 | MC10 | Venture Round | 0 |
| 7/2017 | Gravie | Series C | 0 |
| 6/2015 | Realeve | Series D | 0 |
| 5/2015 | Jiff | Series C | 0 |
| 5/2015 | Realeve | Series D | 0 |
| 4/2015 | Gravie | Series B | 0 |
| 1/2015 | goBalto | Series C | 0 |
| 9/2014 | Jiff | Series B | 0 |
| 3/2014 | Gravie | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
